BioSpace News Archive

Renalytix AI plc, an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces that it has filed a submission seeking clearance of KidneyIntelX™ with the U.S. Food and Drug Administration.

Clearside Biomedical, Inc., a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced the recent issuance of three additional patents in the United States and Europe.

ForwardVue Pharma has secured initial seed round funding in order to advance pre-clinical development of potent long acting anti-angiogenic molecules directed against diabetic eye disease and neovascular age related macular degeneration.

Chemomab Ltd. announces that the European Commission has granted Orphan Drug Designation to its lead drug candidate CM-101 for the treatment of patients with Primary Sclerosing Cholangitis, based on a positive opinion from the Committee for Orphan Medicinal Products of the European Medicines Agency.

The sessions may be accessed from the “Investors & Media” page of Regeneron’s website at http://investor.regeneron.com/events-and-presentations.

CPT Scott Kelly, former NASA astronaut, joins industry experts for inspiring, first-of-its-kind event

Ionis Pharmaceuticals, Inc. announced that it will host a live webcast on Wednesday, September 2nd at 10:00 a.m. Eastern Time to review its cardio-renal franchise.

IMV Inc., a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, announced that the IMV’s executive management team will participate at four upcoming virtual investor conferences in September:

COVID-19 pandemic has caused significant decline in colonoscopies and underscores the value of less invasive screening options for colorectal cancer (CRC)

Can-Fite BioPharma Ltd. today announced that it will be presenting at the 12th annual LD 500 on Tuesday, September 1, 2020 at 9:20 AM EST / 6:20 AM PST.